Deerfield Beach, FL -- (SBWire) -- 05/16/2016 --The report covers forecast and analysis for the metabolomics market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based revenue (USD Million). The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes study of opportunities available in the metabolomics market on a global level.
In order to give the users of this report a comprehensive view on the metabolomics market, we have included a detailed competitive scenario, and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter's five forces model for the metabolomics market has also been included. The study encompasses a market attractiveness analysis, wherein technology segments are benchmarked based on their market size, growth rate and general attractiveness.
Browse the full "Metabolomics Market by Technology (Mass Spectrometry, Capillary Electrophoresis, High Performance Liquid Chromatography, Gas Chromatography, and Nuclear Magnetic Resonance Spectroscopy), Indication (Cardiology and Oncology) for Drug Discovery, Biomarker and Nutrigenomics: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021" report at http://www.marketresearchstore.com/report/metabolomics-market-z55501
The study provides a decisive view on the metabolomics market is segmented on basis of technology, indication, application and region. High performance liquid chromatography, mass spectrometry, capillary electrophoresis, gas chromatography, and nuclear magnetic resonance spectroscopy are the technologies for metabolomics market. Applications include drug discovery, biomarker and nutrigenomics. Cardiology and oncology are the indication for metabolomics. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021.The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil.
The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. Key players profiled in the report include Danaher Corporation, Bruker Corporation, Waters Corporation, Metabolon, Inc., Agilent Technologies, Thermo Fisher Scientific and Shimadzu Corporation among others.
Get sample report at http://www.marketresearchstore.com/report/metabolomics-market-z55501#RequestSample
This report segments for metabolomics market as follows:
Metabolomics Market: Technology Segment Analysis
High performance liquid chromatography
Mass spectrometry
Capillary electrophoresis
Gas chromatography
Nuclear magnetic resonance spectroscopy
Metabolomics Market: Indication Segment Analysis
Cardiology
Oncology
Metabolomics Market: Application Segment Analysis
Drug discovery
Biomarker
Nutrigenomics
Get sample report at http://www.marketresearchstore.com/report/metabolomics-market-z55501#RequestSample
Metabolomics Market: Regional Segment Analysis
North America
US
Europe
Germany
France
UK
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa
Get sample report at http://www.marketresearchstore.com/report/metabolomics-market-z55501#RequestSample
Contact US:
Joel John
3422 SW 15 Street,Suit #8138
Deerfield Beach,Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803
Email: sales@marketresearchstore.com
Website: http://www.marketresearchstore.com
Global Metabolomics Market Set for Rapid Growth, to Reach Above USD 2,500.0 Million in 2021
Global demand for metabolomics market was valued at over USD 675.0 million in 2015 and it is expected to reach above USD 2,500.0 million in 2021, growing at a CAGR of above 25.0% by 2021